Subtype-selective nicotinic receptor antagonists: Potential as tobacco use cessation agents

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 8, 2004, Pages 1863-1867

  Dwoskin, Linda P ^a   Sumithran, Sangeetha P ^a   Zhu, Jun ^a   Deaciuc, A Gabriela ^a   Ayers, Joshua T ^a   Crooks, Peter A ^a  

^a University of Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

N,N' DODECYL BISPICOLINIUM BROMIDE; NICOTINE; NICOTINIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; IC 50; MALE; NONHUMAN; RAT; SMOKING CESSATION; STRUCTURE ACTIVITY RELATION;

ANIMALS; BIOLOGICAL ASSAY; MALE; MOLECULAR STRUCTURE; NICOTINE; NICOTINIC ANTAGONISTS; PICOLINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SMOKING CESSATION; STRUCTURE-ACTIVITY RELATIONSHIP;

NICOTIANA TABACUM;

EID: 1642588151     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2003.10.073     Document Type: Article

References (55)

1. Miller D.K., Sumithran S.P., Dwoskin L.P. J. Pharmacol. Exp. Ther. 302:2002;1113.
2. Hurt R.D., Sachs d.P.L., Glover E.D., Offord K.P., Johnston J.A., Dale L.C., Khayrallah M.A., Schroeder D.R., Glover P.N., Sullivan C.R., Croghan I.T., Sullivan P.M. N. Eng. J. Med. 337:1997;1195.
3. Jorenby D.E., Leischow S.J., Nides M.A., Rennard S.I., Johnston J.A., Hughes A.R., Smith S.S., Muramoto J.L., Daughton D.M., Doan K., Fiore M.C., Baker T.B. N. Eng. J. Med. 340:1999;685.
4. Shiffman S., Johnston J.A., Khayrallah M., Elash C.A., Gwaltney C.J., Paty J.A., Gnys M., Evoniuk G., DeVeaugh-Geiss J. Psychopharmacology. 148:2000;33.
5. Rose J.E., Behm F.M., Westman E.C., Levin E.D., Stein R.M., Ripka G.V. Clin. Pharmacol. Ther. 56:1994;86.
6. Rose J.E., Westman E.C., Behm F.M., Johnson M.P., Goldberg J.S. Pharmacol. Biochem. Behav. 62:1999;165.
7. Koob, G. F. In Advancing from the Ventral Striatum to the Extended Amygdala; McGinty, J. F., Ed.; Ann. N.Y. Acad. Sci., 1999; Vol. 877, p 445.
8. Di Chiara G. Eur. J. Pharmacol. 393:2000;295.
9. Bonci A., Bernardi G., Grillner P., Mercuri N.B. TRENDS Pharmacol. Sci. 24:2003;172.
10. Clarke P.B., Pert A. Brain Res. 348:1985;355.
11. Corrigall W.A., Franklin K.B.J., Coen K.M., Clarke P.B.S. Psychopharmacology. 107:1992;285.
12. McGehee D.S., Role L.W. Annu. Rev. Physiol. 57:1995;521.
13. Teng L., Crooks P.A., Buxton S.T., Dwoskin L.P. J. Pharmacol. Exp. Ther. 283:1997;778.
14. Wonnacott S. Trends Neurosci. 20:1997;92.
15. Laviolette S.R., van der Kooy D. Mol. Psych. 8:2003;50.
16. Rahman S., Zhang J., Corrigall W.A. Neurosci. Lett. 348:2003;61.
17. Luetje C.W., Wada K., Rogers S., Abramson S.N., Tsuji K., Heinemann S., Patrick J. J. Neurochem. 55:1990;632.
18. Cartier G.E., Yoshikami D., Gray W.R., Luo S., Olivera B.M., McIntosh J.M. J. Biol. Chem. 271:1996;7522.
19. Schulz D.W., Zigmond R.E. Neurosci. Lett. 98:1989;310.
20. Grady S., Marks M.J., Wonnacott S., Collins A.C. J. Neurochem. 59:1992;848.
21. Grady S.R., Murphy K.L., Cao J., Marks M.J., McIntosh J.M., Collins A.C. J. Pharmacol. Exp. Ther. 301:2002;651.
22. Kaiser S.A., Soliakov L., Harvey S.C., Luetje C.W., Wonnacott S. J. Neurochem. 70:1998;1069.
23. Kaiser S., Wonnacott S. Mol. Pharmacol. 58:2000;312.
24. Kulak J.M., Nguyen T.A., Olivera B.M., McIntosh J.M. J. Neurosci. 17:1997;5263.
25. Rapier C., Lunt G.G., Wonnacott S. J. Neurochem. 54:1990;937.
26. Sharples C.G., Kaiser S., Soliakov L., Marks M.J., Collins A.C., Washburn M., Wright E., Spencer J.A., Gallagher T., Whiteaker P., Wonnacott S. J. Neurosci. 20:2000;2783.
27. Picciotto M.R., Zoli M., Rimondini R., Lena C., Marubio L.M., Pich E.M., Fuxe K., Changeux J.P. Nature. 391:1998;173.
28. Marubio L.M., Gardier A.M., Durier S., David D., Klink R., Arroyo-Jimenez M.M., McIntosh J.M., Rossi F., Champtiaux N., Zoli M., Changeux J.P. Eur. J. Neurosci. 17:2003;1329.
29. Champtiaux N., Cotti C., Cordero-Erausquin M., David D.J., Przybylski C., Lena C., Clementi F., Moretti M., Rossi F.M., Le Novere N., McIntosh J.M., Gardier A.M., Changeux J.P. J. Neurosci. 23:2003;7820.
30. Wada E., Wada K., Boulter J., Deneris E., Heinemann S., Patrick J., Swanson L.W. J. Comp. Neurol. 284:1989;314.
31. Deneris E.S., Boulter J., Swanson L.W., Patrick J., Heinemann S. J. Biol. Chem. 264:1989;6268.
32. Dineley-Miller K., Patrick J. Mol. Brain Res. 16:1992;339.
33. Charpantier E., Barneoud P., Moser P., Besnard F., Sgard F. NeuroReport. 9:1998;3097.
34. Arroyo-Jimenez M.M., Bourgeois J.P., Marubio L.M., Le Sourd A.M., Ottersen O.P., Rinvik E., Fairen A., Changeux J.P. J. Neurosci. 19:1999;6475.
35. Le Novere N., Zoli M., Changeux J.P. Eur. J. Neurosci. 8:1996;2428.
36. Goldner F.M., Dineley K.T., Patrick J.W. Neuroreport. 8:1997;2739.
37. Klink R., de Kerchove d'Exaerde A., Zoli M., Changeux J.P. J. Neurosci. 21:2001;1452.
38. Zoli M., Moretti M., Zanardi A., McIntosh J.M., Clementi F., Gotti C. J. Neurosci. 22:2002;8785.
39. Champtiaux N., Han Z.Y., Bessis A., Rossi F.M., Zoli M., Marubio L., McIntosh J.M., Changeux J.P. J. Neurosci. 22:2002;1208.
40. Gray R., Rajan A.S., Radcliffe K.A., Yakehiro M., Dani J.A. Nature. 383:1996;713.
41. Wonnacott S., Kaiser S., Mogg A., Soliakov L., Jones I.W. Eur. J. Pharmacol. 393:2000;51.
42. Crooks P.A., Ravard A., Wilkins L.H., Teng L.H., Buxton S.T., Dwoskin L.P. Drug Dev. Res. 36:1995;91.
43. Dwoskin L.P., Xu R., Ayers J., Crooks P.A. Exp. Opin. Ther. Patents. 10:2000;1561.
44. Dwoskin L.P., Crooks P.A. J. Pharmacol. Exp. Ther. 298:2001;395.
45. Wilkins L.H., Haubner A., Ayers J.T., Crooks P.A., Dwoskin L.P. J. Pharmacol. Exp. Ther. 301:2002;1088.
46. Wilkins L.H., Grinevich V.P., Ayers J.T., Crooks P.A., Dwoskin L.P. J. Pharmacol. Exp. Ther. 304:2003;400.
47. Everett A.J., Lowe L.A., Wilkinson S. Chem. Commun. Chem. Soc. London. 1970;1020.
48. Koelle, G. B. In The Pharmacological Basis of Therapeutics, 5th Ed.; Goodman, L. S., Gilman, A., Eds.; MacMillan Pub. Co.: New Yourk, 1975; p 565.
49. Khromov-Borisov N., Michelson M. Pharmacol. Rev. 18:1966;1051.
50. Michelson M., Zaimal E. Acetylcholine. An Approach to the Molecular Mechanism of Action. 1973;Pergammon Press, Oxford.
51. Paton W., Zaimis E.J. Nature (London). 162:1948;810.
52. Barlow R.B., Ing H.R. Br. J. Pharmacol. 3:1948;298.
53. Dwoskin L.P., Zahniser N.R. J. Pharmacol. Exp. Ther. 239:1986;442.
54. Zumstein A., Karduck W., Starke K. Naunyn-Schmiedeberg's Arch. Pharmacol. 316:1981;205.
55. Bradford M.M. Anal. Biochem. 72:1976;248.